Download PDF
Dtsch Med Wochenschr 2008; 133(12): 591-594
DOI: 10.1055/s-2008-1067291
Kommentar | Commentary
Kardiologie, Pathophysiologie
© Georg Thieme Verlag KG Stuttgart · New York

Kardiologische Optionen der Akutprotektion des reperfundierten Myokards

Cardiological options for acute protection of the reperfused myocardiumF. Breuckmann1 , G. Heusch2 , R. Erbel1 , S. Philipp1
  • 1Klinik für Kardiologie, Westdeutsches Herzzentrum Essen
  • 2Institut für Pathophysiologie, Universität Duisburg-Essen
Further Information

Publication History

eingereicht: 3.12.2008

akzeptiert: 14.2.2008

Publication Date:
12 March 2008 (online)

Also available at
   Permissions and Reprints
Preview

Schlüsselwörter

Myokardinfarkt - Reperfusion - Postkonditionierung

Key words

myocardial infarction - reperfusion - postconditioning

Literatur

  • 1 Armstrong P W, Adams P X, Al-Khalidi H R, Hamm C, Holmes D, O’Neill W, Todaro T G, Vahanian A, van de Werf F, Granger C B. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.  Amer Heart J. 2005;  149 (3) 402-7
    Search in Google Scholar
  • 2 Darling C E, Solari P B, Smith C S, Furman M I, Przyklenk K. ‘Postconditioning’ the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection.  Basic Res Cardiol. 2007;  102 (3) 274-278
    Search in Google Scholar
  • 3 Heusch G, Schulz R. Ischämische Prä- und Postkonditionierung.  Dtsch Med Wochenschr. 2006;  39 2169-75
    Search in Google Scholar
  • 4 Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.  Lancet. 2007;  370 (9597) 1483-93
    Search in Google Scholar
  • 5 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.  Circulation. 1986;  74 (5) 1124-36
    Search in Google Scholar
  • 6 Philipp S, Yang X -M, Cui L, Davis A, Downey J M, Cohen M V. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.  Cardiovasc Res. 2006;  70 (2) 308-14
    Search in Google Scholar
  • 7 Roe M. ACC 07: Die DELTA MI-Studie.  Herz. 2007;  32 250
    Search in Google Scholar
  • 8 Ross A M, Gibbons R J, Stone G W, Kloner R A, Alexander R W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).  J Am Coll Cardiol. 2005;  45 (11) 1775-80
    Search in Google Scholar
  • 9 Staat P, Rioufol G, Piot C, Cottin Y, Cung T T, L’Huillier I, Aupetit J F, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M. Postconditioning the human heart.  Circulation. 2005;  112 (14) 2143-8
    Search in Google Scholar
  • 10 Zhao Z Q, Corvera J S, Halkos M E, Kerendi F, Wang N -P, Guyton R A, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.  Am J Physiol. 2003;  285 H579-H588
    Search in Google Scholar

Dr. med. Frank Breuckmann

Klinik für Kardiologie, Westdeutsches Herzzentrum Essen, Universität Duisburg-Essen

Hufelandstr. 55

45122 Essen

Phone: 0201/723-4888

Fax: 0201/723-5401

Email: frank.breuckmann@uk-essen.de